ResMed Inc.

10/27/2025 | Press release | Distributed by Public on 10/26/2025 15:04

Resmed Introduces Full Face Fabric Mask Designed for Comfort and Improved Sleep Health in Australia

  • The new AirTouch™ F30i Comfort full face CPAP mask is designed to combine softness, breathability, and a reliable seal to provide exceptional comfort.
  • AirTouch F30i Comfort earned Gold at the 2025 Australian Good Design Awards, underscoring Resmed's commitment and expertise in developing solutions that help people live better lives.

SYDNEY, October 27, 2025 - Resmed (NYSE: RMD, ASX: RMD), the world's leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the launch of the AirTouch™ F30i Comfort in Australia, a new CPAP (continuous positive airway pressure) full face mask. With a soft, breathable and moisture-wicking1 fabric, the AirTouch F30i Comfort is designed to help more people start and stay on CPAP therapy.

The AirTouch F30i Comfort reflects Resmed's dedication to its 2030 goal of empowering 500 million people to achieve their full health potential. The mask earned Gold at the 2025 Australian Good Design Awards earlier this month, underscoring Resmed's focus on combining clinical performance with user-friendly design. The AirTouch F30i Comfort complements the 2024 launch of the AirTouch N30i, a nasal cushion mask that features a fabric-wrapped frame and combines softness, breathability, and a reliable seal designed to deliver a more comfortable experience.

"Resmed creates health technologies that people love and trust," said Justin Leong, chief product officer at Resmed. "That means making it easier for people to start and stay on CPAP therapy, helping them sleep, breathe, and live healthier lives. With the AirTouch F30i Comfort, we're raising the bar on comfort and innovation to help more people get the good sleep they deserve."

Obstructive Sleep Apnea (OSA) is a chronic condition that affects over one billion people globally.2 3 Resmed's 2025 Global Sleep Survey found that nearly 19% of Australian respondents have been or live with someone who has been diagnosed with OSA. OSA is characterised by frequent reductions or arrest of the airflows during sleep due to partial or total collapse of the airway.4 The condition can impair daily functioning and significantly increase the risk of serious comorbidities such as hypertension, diabetes, cardiovascular disease, and stroke.5

Key Features of the AirTouch F30i Comfort

  • Designed for comfort - Featuring Resmed's patented ComfiSoft™ fabric-covered cushion and moisture-wicking fabric1, the mask is designed to deliver maximum comfort without compromising on seal.

  • Breakthrough innovation - Pushing the boundaries of textile and manufacturing innovation, the AirTouch F30i Comfort combines durability and softness designed to gently contour to the face.

  • Customised Fit - AirTouch F30i Comfort is developed using thousands of digital biomarkers to provide a tailored fit. Available in three cushion sizes-Small-Wide, Medium, and Large-and three frame sizes - Small, Standard and Large, the AirTouch F30i is designed to deliver greater personalisation than ever.

The AirTouch F30i Comfort will be available across Australia beginning October 27, 2025. The mask is compatible with Resmed's AirCurve™ 11, AirSense™ 11, AirCurve 10, AirSense 10, S9 Autoset, and select VPAP devices. For more information and a full list of compatible devices, visit Resmed.com.au/AirTouchF30i.

About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We're relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we're redefining sleep health at Resmed.com and follow @Resmed.

For Media: Caela [email protected]@resmed.com

For Investors:Salli [email protected]@resmed.com


1 Resmed internal testing for the moisture-wicking properties of fabric, ID: A5498268

2 Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687-698.

3 Boers, et al. Projecting the 30-year burden of obstructive sleep apnoea in the USA: a prospective modelling study. Lancet Respir Med. 2025;10.1016/S2213-2600(25)00243-7.

4 Garvey JF, Pengo MF, Drakatos P, Kent BD. Epidemiological aspects of obstructive sleep apnea. J Thorac Dis. 2015;7(5):920-929. doi:10.3978/j.issn.2072-1439.2015.04.52

5 Lévy P, Kohler M, McNicholas WT, et al. Obstructive sleep apnoea syndrome. Nature Reviews Disease Primers. 2015;1:15015.

ResMed Inc. published this content on October 27, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 26, 2025 at 21:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]